Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer
Mario I. Fernández(Clínica Alemana), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Raghunandan Vikram(The University of Texas MD Anderson Cancer Center), Lambertus A. Kiemeney(Radboud University Nijmegen), Michael S. Cookson(University of Oklahoma Health Sciences Center), Rafael Sanchez‐Salas(Institute Mutualiste Montsouris), Alina Vrieling(Radboud University Nijmegen), Peter E. Clark(Levine Cancer Institute), Mark S. Soloway(Memorial Regional Hospital), Maurizio Brausi(De Agostini (Italy)), H. Barton Grossman(The University of Texas MD Anderson Cancer Center), Bernard Malavaud(Université Toulouse III - Paul Sabatier), Makarand Khochikar(Shri Siddhivinayak Ganapati Cancer Hospital), Robert S. Svatek(The University of Texas at San Antonio Health Science Center)
Cited by 59
Related Papers
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845